Masimo to Integrate Imprivata Medical Device Access Authentication Technology into Its Root® and Iris® Hospital Automation Platform

▤ Summary

IRVINE, Calif. & LEXINGTON, Mass.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced a partnership with Imprivata®, the digital identity company for healthcare, to integrate Imprivata Medical Device Access – streamlined, secure authentication to medical devices for clinical users – into Masimo’s Hospital Automation solutions, featuring the Root® Patient Monitoring and Connectivity Platform and Iris Gateway®. “We are excited to work toward bringing Imprivata’s authentication technology to Masimo customers, to enhance their experience with our monitoring and automation solutions and to help them stay focused on improving patient outcomes. “By partnering with Masimo, we’re pleased to give our joint customers the ability to implement and enforce the security of sensitive information captured on Root and Iris platforms, without affecting clinical workflows.” Masimo Root is a powerful, expandable patient monitoring and connectivity hub that integrates an array of technologies, devices, and systems to provide multimodal monitoring and connectivity solutions in a single, clinician-centric platform. Masimo hospital automation and connectivity solutions are centered around the Iris® platform, and include Iris Gateway®, Patient SafetyNet, Replica™, Halo ION™, UniView™, and Doctella™. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

▦ Linked Companies

Imprivata

$100M to $250M